Biosynth's Peptide Division successfully completed GMP inspection in Lelystad
Biosynth announces today that its site in Lelystad, The Netherlands, successfully passed the recent GMP inspection by the Inspectie Gezondheidszorg en Jeugd (IGJ) on January 25, 2023. The scope of the inspection was the Quality Management System of the site. The inspection, carried out by the IGJ confirmed the ...
Source: pharmiweb.com